NPPB and heart failure: This applies mainly to highly-selected low-risk candidates (age <65 years, normal NT-proBNP and cardiac troponins, glomerular filtration rate > 50 mL/min), given the high treatment-related mortality, particularly in patients with heart failure and multi-organ involvement [11].